Sekisui Diagnostics LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Sekisui Diagnostics LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C12096
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sekisui Diagnostics LLC (Sekisui Diagnostics), a subsidiary of Sekisui Chemical Co Ltd, is a medical device company that develops, manufactures and supplies clinical diagnostic and research products. The company provides products such as coagulation, clinical chemistry, virotech products, OSOM rapid tests and enzymes, among others. It provides clinical chemistry products such as acetaminophen, ammonia controls, alkaline phosphatase, alanine aminotransferase, albumin and ammonia, among others. Sekisui Diagnostics provides coagulation products such as alpha-2-antiplasmin deficient human plasma, alpha-thrombin human, annexin V ELISA and antithrombin III, among others. The company’s technology integrates biological raw materials such as enzymes, antigens and antibodies with reagents, test devices (OSOM and Virotech products) and instrumentation. It operates in Lexington, Stamford, San Diego and Exton, the US. Sekisui Diagnostics is headquartered in Lexington, Massachusetts, the US.

Sekisui Diagnostics LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sekisui Diagnostics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sekisui Diagnostics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sekisui Diagnostics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sekisui Diagnostics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Sekisui Diagnostics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sekisui Diagnostics LLC, Medical Equipment, Deal Details 10
Partnerships 10
Sekisui Diagnostics Enters into Distribution Agreement with Mesa Biotech 10
Sekisui Diagnostics Enters into Co-Marketing Agreement with Qualigen 11
Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 12
Sekisui Diagnostics LLC – Key Competitors 13
Sekisui Diagnostics LLC – Key Employees 14
Sekisui Diagnostics LLC – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Strategy And Business Planning 16
Oct 11, 2017: Aided by provincial government, Sekisui completes renovation and announces expansion 16
Corporate Communications 17
Jun 22, 2018: Bob Schruender, CEO Joins Sekisui Medical Board of Directors 17
Other Significant Developments 18
Nov 01, 2017: Sekisui Diagnostics Selects Ginolis for Automated Production Solution 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Sekisui Diagnostics LLC, Medical Equipment, Key Facts 2
Sekisui Diagnostics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Sekisui Diagnostics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sekisui Diagnostics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Sekisui Diagnostics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sekisui Diagnostics LLC, Deals By Market, 2012 to YTD 2018 8
Sekisui Diagnostics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Sekisui Diagnostics Enters into Distribution Agreement with Mesa Biotech 10
Sekisui Diagnostics Enters into Co-Marketing Agreement with Qualigen 11
Abbott Labs Enters into Agreement with Sekisui Diagnostics for Coagulation Testing 12
Sekisui Diagnostics LLC, Key Competitors 13
Sekisui Diagnostics LLC, Key Employees 14
Sekisui Diagnostics LLC, Other Locations 15
Sekisui Diagnostics LLC, Subsidiaries 15

List of Figures
Sekisui Diagnostics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Sekisui Diagnostics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Sekisui Diagnostics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Sekisui Diagnostics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Sekisui Diagnostics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Sekisui Diagnostics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Sekisui Diagnostics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Sekisui Diagnostics LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Sekisui Diagnostics LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Canadian Western Bank Group (CWB):企業の財務・戦略的SWOT分析
    Canadian Western Bank Group (CWB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bayer AG (BAYN)-製薬・医療分野:企業M&A・提携分析
    Summary Bayer AG (Bayer) carries out the research, development, production and commercialization of products in the areas of human and animal health care, and agriculture. It provides pharmaceuticals for cardiology, women’s healthcare, oncology, hematology, ophthalmology, infection and other indicat …
  • Johnson Electric Holdings Limited (179):企業の財務・戦略的SWOT分析
    Johnson Electric Holdings Limited (179) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Wartsila Corp (WRT1V):企業の財務・戦略的SWOT分析
    Wartsila Corp (WRT1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • GWA Group Limited (GWA):企業の財務・戦略的SWOT分析
    GWA Group Limited (GWA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • LBT Innovations Limited (LBT)-医療機器分野:企業M&A・提携分析
    Summary LBT Innovations Limited (LBT) is a medical device company that designs, develops and commercializes various products and automation technologies for the preparation and analysis of microbiology culture specimens, and microbiology and diagnostic laboratory services. It offers MicroStreak tech …
  • Resolute Energy Corp (REN):石油・ガス:M&Aディール及び事業提携情報
    Summary Resolute Energy Corp (Resolute), a subsidiary of Resolute Holdings LLC, is an oil and gas company that acquires and operates large-scale oil and gas properties. The company mangaes complex enterprise and undertakes complex transactions. It offers considerable acquisitions of producing proper …
  • Security Networks AG:企業の戦略・SWOT・財務情報
    Security Networks AG - Strategy, SWOT and Corporate Finance Report Summary Security Networks AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Daiho Corporation
    Daiho Corporation - Strategy, SWOT and Corporate Finance Report Summary Daiho Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Gilead Sciences Inc (GILD)-医療機器分野:企業M&A・提携分析
    Summary Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of medicines for the treatment of cardiovascular and respiratory diseases, inflammation, liver diseases, cancer and human immunodeficiency virus (HIV) in …
  • Investimentos, Participacoes e Gestao SA (INA):企業の財務・戦略的SWOT分析
    Investimentos, Participacoes e Gestao SA (INA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • Sichuan Kelun Pharmaceutical Co Ltd (002422):医療機器:M&Aディール及び事業提携情報
    Summary Sichuan Kelun Pharmaceutical Co., Ltd. (Kelun) is engaged in manufacturing and distribution of IV Solutions. The company’s products portfolio includes glucose injection, sodium chloride injection, glucose and sodium chloride injection, ringer’s injection, lactated ringer’s injection, compoun …
  • Societe Tunisienne de l’Electricite et du Gaz:企業の戦略的SWOT分析
    Societe Tunisienne de l'Electricite et du Gaz - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Mobidiag Ltd:企業の製品パイプライン分析2018
    Summary Mobidiag Ltd (Mobidiag) is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Prove-it. Its Amplidiag is a diagnostic test for high-volume screening of gastrointestin …
  • Zai Lab Ltd (ZLAB):製薬・医療:M&Aディール及び事業提携情報
    Summary Zai Lab Ltd (Zai Lab) is a biopharmaceutical company that discovers, develops and manufactures transformative medicines for cancer, autoimmune and infectious diseases. The company’s pipeline products include ZL-2306, ZL-2401, FPA144, EXT2514SUL, ZL-2301, ZL-3101, ZL-2302 and ZL-1101. It deve …
  • PolyPid Ltd (POLY):製薬・医療:M&Aディール及び事業提携情報
    Summary PolyPid Ltd (PolyPid) is a pharmaceutical company that develops manufactures and commercializes therapies for the treatment of various medical conditions including infection, pain, inflammation and cancer. The company’s pipeline product candidates include D-Plex100, an antibiotic drug reserv …
  • Society for Worldwide Interbank Financial Telecommunication:企業の戦略的SWOT分析
    Society for Worldwide Interbank Financial Telecommunication - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, k …
  • Walmart Chile S.A.:企業の戦略的SWOT分析
    Walmart Chile S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • J B Chemicals and Pharmaceuticals Ltd (JBCHEPHARM)-製薬・医療分野:企業M&A・提携分析
    Summary J B Chemicals and Pharmaceuticals Ltd (JBCPL) is a pharmaceutical company that provides contract manufacturing services. The company manufacturers tablets, lozenges, injectables, gels, creams, ointments, liquid herbal syrups and capsules. Its services include optimization of formulations, sc …
  • Strabag SE:企業の戦略・SWOT・財務情報
    Strabag SE - Strategy, SWOT and Corporate Finance Report Summary Strabag SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆